Adrenaline of epinephrine can be seen in autonomic neuropathy or following adrenalectomy. Failure of the adrenal cortex, as with Addisons disease, can suppress epinephrine secretion as the activity of the synthesing enzyme, phenylethanolamine-"N"-methyltransferase, depends on the high concentration of cortisol that drains from the cortex to the medulla. In 1901, Jokichi Takamine patented a purified extract from the adrenal glands, and called it "adrenalin" (from the Latin for "on top of the kidneys" ("ad" and "renal"), which was trademarked by Parke, Davis & Co in the US. The British Approved Name and European Pharmacopoeia term for this drug is hence "adrenaline".
Autonomic networking features, but also burdens existing networking infrastructure with more and more tasks that sooner or later will not be manageable by human intervention alone. Another important aspect is the price of manually controlling huge numbers of vitally important devices of current network infrastructures. The autonomic nervous system (ANS) is the part of the nervous system of the higher life forms that is not consciously controlled. It regulates bodily functions and the activity of specific organs. As proposed by IBM, future communication systems might be designed in a similar way to the ANS. As autonomics conceptually derives from biological entities such